Comparison of clinical and pathological characteristics between screen-detected and self-detected breast cancers: a Hong Kong study

Comparison of pathological characteristics between self-detected and screen-detected invasive breast cancers in Chinese women: a retrospective study

“…Specifically, we identified the prognostic advantages, based on pathological findings at diagnosis, for asymptomatic patients with screen-detected cancers. Comparable to our results (66.7–75.0% vs 17.1–40.4%), higher proportions of screen-detected patients were reported to have stage T1 cancer compared with self-detected groups in studies in both Korea (59.2% vs 31.7%) ( Kim et al, 2012 ) and Hong Kong (44.7% vs 33.4%) ( Lau et al, 2016 ). A study in Singapore also indicated that screening was an independent factor for better clinical staging at presentation, after adjusting for race and menopausal status ( Wang, Tan & Chow, 2011 ).…”

“…Screen-detected cancers tend to be of a smaller size, to have better differentiation, and to be at an earlier stage ( Crispo et al, 2013 ). In a study carried out in a private hospital in Hong Kong, patients with screen-detected breast cancer had greater numbers of favorable pathological characteristics than a self-detected group ( Lau et al, 2016 ). Therefore, the second aim of this study was to compare the pathological characteristics of the self-detected (symptomatic) and screen-detected (asymptomatic) invasive breast cancer in Tianjin, China.…”

Safety and efficacy of magnetic seed localisation of non-palpable breast lesions: pilot study in a Chinese population

“…With the increasing use of screening mammography and advances in neoadjuvant therapy, tumours at the time of surgery are more often non-palpable. [1][2][3][4][5][6][7] Accurate image-guided localisation is the key to successful excision of these lesions.…”